CLEMEDI
Clemedi develops in vitro diagnostic tests for infectious diseases, by uniting two novel technologies – Next-generation Sequencing and Machine learning. They will contribute to limiting deaths caused by antibiotic resistant bacteria, projected to reach 10 million annually in 2050! Our diagnostic tests support doctors’ decision-making by enabling him or her to give a timely and personalized antibiotic therapy. Ultimately, patients suffering from infectious diseases will benefit with their product.
CLEMEDI
Industry:
Biotechnology Health Care
Founded:
2018-01-01
Address:
Schlieren, Zurich, Switzerland
Country:
Switzerland
Website Url:
http://www.clemedi.com
Total Employee:
1+
Status:
Active
Contact:
+41 77 98 040 61
Email Addresses:
[email protected]
Total Funding:
30.71 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Font Awesome
Current Employees Featured
Founder
Investors List
MassChallenge
MassChallenge investment in Non Equity Assistance - Clemedi
Venture Kick
Venture Kick investment in Grant - Clemedi
Venture Kick
Venture Kick investment in Grant - Clemedi
Official Site Inspections
http://www.clemedi.com
- Host name: boethin.uberspace.de
- IP address: 185.26.156.96
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "Clemedi"
Home – Clemedi
Clemedi provides complete information to clinicians when most needed. Early. It renders comprehensive information more quickly leading to faster, targeted therapy thus creating …See details»
Clemedi - Crunchbase Company Profile & Funding
Clemedi develops in vitro diagnostic tests for infectious diseases, by uniting two novel technologies – Next-generation Sequencing and Machine learning. They will contribute to …See details»
About - Clemedi
To address this, Clemedi is developing in vitro molecular diagnostic test kits to diagnose drug resistant infections directly from patient samples, within 24 hours. Our tests combine molecular …See details»
Clemedi AG – Swiss Biotech
Clemedi combines DNA sequencing and artificial intelligence to recommend the optimal antibiotic therapy for every patient. Our products help with managing infectious diseases such as tuberculosis, sexually transmitted infections or …See details»
Clemedi Company Profile 2024: Valuation, Funding & Investors
Clemedi General Information Description. Developer of a disease management platform designed to render comprehensive information for targeted therapy. The company's platform combines …See details»
Clemedi - Company Profile - Tracxn
Nov 8, 2024 Clemedi ranks 315th among 694 active competitors. 213 of its competitors are funded while 127 have exited. Overall, Clemedi and its competitors have raised over $14.2B in …See details»
Clemedi AG Company Profile | Schlieren, ZÜRICH, Switzerland ...
Find company research, competitor information, contact details & financial data for Clemedi AG of Schlieren, ZÜRICH. Get the latest business insights from Dun & Bradstreet.See details»
Clemedi - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . May 15, 2019: ... Clemedi . …See details»
Clemedi AG - Schlieren, Switzerland - bionity.com
Clemedi is a paradigm shift Clemedi provides complete information to clinicians when most needed: early. It renders comprehensive information more quickly leading to faster, targeted …See details»
Clemedi - LinkedIn
Clemedi is a paradigm shift Clemedi provides complete information to clinicians when most needed: early. It renders comprehensive information more quickly leading to faster, targeted …See details»
Our Team – Clemedi
Dr. Houda Youssefi, Director of sales North Africa. Board of Directors. Prof. Thorsten BuchSee details»
clemedi - VentureRadar
The basic techniques of clinical microbiology have barely changed since the days of Robert Koch, the founder of the field. Far too many laboratories... ... Find out ...See details»
Clemedi - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Clemedi . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 1. About. Clemedi has 1 …See details»
Clemedi AG - startup.ch
Clemedi AG: The current diagnosis of anti-microbial resistant infections is largely based on culturing bacteria in the presence of various antibiotics. This is both labor and time-consuming, …See details»
Clemedi AG concludes license agreement for detecting latent ...
Dec 19, 2022 Clemedi AG was founded in 2019 to develop sequencing-based tests for infectious diseases. It has developed a technology platform combining targeted sequencing …See details»
Institut für Labortierkunde (LTK) - Institute of Laboratory ... - UZH
At Clemedi we develop in vitro diagnostic tests for infectious diseases, by uniting two novel technologies: Next-generation Sequencing and Machine learning. We will contribute to limiting …See details»
News - Clemedi
Clemedi Update Q4 2022. Dear investors, partners, supporters and friends, we closed the year by increasing our marketing efforts. You might have noticed an increased frequency of linkedIn …See details»
Press Release - Clemedi
Oct 31, 2022 Clemedi has developed a next-generation sequencing (NGS) based test called Tuberculini, that can recognise resistance to all major therapeutic agents used to treat …See details»
Clemedi Update Q1 2022 – Clemedi
Apr 13, 2022 Clemedi is grasping the opportunity introduced in December by the European Commission, that has introduced grace periods for IVD products certified under the current …See details»